stoxline Quote Chart Rank Option Currency Glossary
  
Boundless Bio, Inc. Common Stock (BOLD)
14.656  -1.344 (-8.4%)    03-28 13:41
Open: 14.25
High: 15
Volume: 794,906
  
Pre. Close: 16
Low: 14.1
Market Cap: 0(M)
Technical analysis
2024-03-28 1:17:15 PM
Short term     
Mid term     
Targets 6-month :  517.24 1-year :  604.13
Resists First :  442.84 Second :  517.24
Pivot price 420.47
Supports First :  406.17 Second :  383.51
MAs MA(5) :  436.41 MA(20) :  417.67
MA(100) :  362.28 MA(250) :  292.38
MACD MACD :  11.7 Signal :  10
%K %D K(14,3) :  89.6 D(3) :  87.4
RSI RSI(14): 66.5
52-week High :  442.84 Low :  184.5
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ BLD ] has closed below upper band by 15.9%. Bollinger Bands are 12.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 438.7 - 441.34 441.34 - 443.88
Low: 426.03 - 429.17 429.17 - 432.17
Close: 433.65 - 438.28 438.28 - 442.72
Company Description

Headline News

Thu, 28 Mar 2024
Boundless Bio's 'BOLD' IPO Reels In $100M for a New Kind of Cancer Drug - MedCity News

Thu, 28 Mar 2024
Boundless Bio raises $100m as IPO market rouses - Pharmaceutical Technology

Thu, 28 Mar 2024
Boundless Bio Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Thu, 28 Mar 2024
Boundless Bio Launches $100M IPO to Advance Cancer Therapy Candidates - BioSpace

Thu, 28 Mar 2024
Boundless Bio prices $100M IPO at $16 per share - MSN

Wed, 27 Mar 2024
Boundless Bio Announces Pricing of Initial Public Offering - The Bakersfield Californian

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Industry:
Shares Out 32 (M)
Shares Float 31 (M)
Held by Insiders 0.4 (%)
Held by Institutions 97.8 (%)
Shares Short 506 (K)
Shares Short P.Month 505 (K)
Stock Financials
EPS 19.34
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 81.18
Profit Margin 11.8 %
Operating Margin 16.4 %
Return on Assets (ttm) 11.4 %
Return on Equity (ttm) 27.3 %
Qtrly Rev. Growth 1.7 %
Gross Profit (p.s.) 0
Sales Per Share 163.15
EBITDA (p.s.) 32.37
Qtrly Earnings Growth 1.8 %
Operating Cash Flow 849 (M)
Levered Free Cash Flow 679 (M)
Stock Valuations
PE Ratio 22.75
PEG Ratio 2
Price to Book value 5.42
Price to Sales 2.69
Price to Cash Flow 16.47
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android